Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1989 1
1990 2
1992 1
1993 3
1994 1
1995 4
1996 4
1997 1
1998 2
1999 1
2000 4
2001 8
2002 1
2003 1
2004 2
2005 3
2006 1
2007 2
2008 1
2009 4
2010 1
2011 2
2012 2
2013 2
2014 2
2015 1
2016 3
2017 1
2018 1
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

62 results
Results by year
Filters applied: . Clear all
Page 1
Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications.
Ardini E, Menichincheri M, Banfi P, Bosotti R, De Ponti C, Pulci R, Ballinari D, Ciomei M, Texido G, Degrassi A, Avanzi N, Amboldi N, Saccardo MB, Casero D, Orsini P, Bandiera T, Mologni L, Anderson D, Wei G, Harris J, Vernier JM, Li G, Felder E, Donati D, Isacchi A, Pesenti E, Magnaghi P, Galvani A. Ardini E, et al. Among authors: Degrassi A. Mol Cancer Ther. 2016 Apr;15(4):628-39. doi: 10.1158/1535-7163.MCT-15-0758. Epub 2016 Mar 3. Mol Cancer Ther. 2016. PMID: 26939704 Free article.
Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.
Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M. Rainone V, et al. Among authors: Degrassi A. PLoS One. 2016 Jan 21;11(1):e0146622. doi: 10.1371/journal.pone.0146622. eCollection 2016. PLoS One. 2016. PMID: 26795765 Free PMC article.
miR-494-3p is a novel tumor driver of lung carcinogenesis.
Faversani A, Amatori S, Augello C, Colombo F, Porretti L, Fanelli M, Ferrero S, Palleschi A, Pelicci PG, Belloni E, Ercoli G, Degrassi A, Baccarin M, Altieri DC, Vaira V, Bosari S. Faversani A, et al. Among authors: Degrassi A. Oncotarget. 2017 Jan 31;8(5):7231-7247. doi: 10.18632/oncotarget.13933. Oncotarget. 2017. PMID: 27980227 Free PMC article.
Exogenous adult postmortem neural precursors attenuate secondary degeneration and promote myelin sparing and functional recovery following experimental spinal cord injury.
Carelli S, Giallongo T, Marfia G, Merli D, Ottobrini L, Degrassi A, Basso MD, Di Giulio AM, Gorio A. Carelli S, et al. Among authors: Degrassi A. Cell Transplant. 2015;24(4):703-19. doi: 10.3727/096368914X685140. Epub 2014 Oct 8. Cell Transplant. 2015. PMID: 25299753 Free article.
Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy.
Rainone V, Martelli C, Ottobrini L, Biasin M, Texido G, Degrassi A, Borelli M, Lucignani G, Trabattoni D, Clerici M. Rainone V, et al. Among authors: Degrassi A. PLoS One. 2016 Mar 2;11(3):e0151008. doi: 10.1371/journal.pone.0151008. eCollection 2016. PLoS One. 2016. PMID: 26934596 Free PMC article. No abstract available.
Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.
Albanese C, Alzani R, Amboldi N, Degrassi A, Festuccia C, Fiorentini F, Gravina G, Mercurio C, Pastori W, Brasca M, Pesenti E, Galvani A, Ciomei M. Albanese C, et al. Among authors: Degrassi A. Br J Pharmacol. 2013 May;169(1):156-66. doi: 10.1111/bph.12112. Br J Pharmacol. 2013. PMID: 23347136 Free PMC article.
62 results
Jump to page
Feedback